Literature DB >> 8804938

Uveitis as a presenting feature of chronic sarcoidosis.

G Rizzato1, M Angi, P Fraioli, L Montemurro, E Pilotto, A Tommasini.   

Abstract

Uveitis is often a manifestation of sarcoidosis. Less well-recognized, however, is the development of uveitis several years before the diagnosis of systemic sarcoidosis. The possibility that presentation of uveitis is a marker for the chronicity of sarcoidosis has never been investigated. The aim of this work was to evaluate, in a Caucasian population, the epidemiology of uveitis as the primary manifestation of sarcoidosis with long-term follow-up, and the relationship of uveitis to the chronicity of sarcoidosis. The records of 1,156 Caucasian patients with histologically proven sarcoidosis, first seen in the period 1976-1992, were reviewed. In patients in whom uveitis was the primary feature of sarcoidosis, the following parameters were identified: systemic manifestations; time interval between the diagnosis of uveitis and sarcoidosis; therapy; the evolution of chest radiographic image over time; chronicity; the relationship between sarcoidosis and uveitis; and, finally, status in October 1994. In nine patients, uveitis was the reason for seeking medical treatment, resulting in the discovery of systemic sarcoidosis, which was then found to be chronic in 7 out of 9 cases. In an additional eight patients, uveitis preceded the diagnosis of systemic sarcoidosis by 1-11 yrs, and yet most subjects had systemic manifestations that went unrecognized during this time period, with chest radiograph at the time of diagnosis suggesting a long-standing chronic disease. Thus, uveitis appeared to be the primary manifestation of sarcoidosis in 17 of the 1,156 patients studied (1.5%). In conclusion, any uveitis of unknown origin may be due to sarcoidosis, although its systemic manifestations may not occur for up to 11 yrs. Uveitis patients need a very long-term follow-up, including periodic diagnostic tests for systemic sarcoidosis. Furthermore, when uveitis precedes the systemic symptoms and diagnosis of sarcoidosis by more than one year, it may be regarded as a marker of the chronicity of sarcoidosis.

Entities:  

Mesh:

Year:  1996        PMID: 8804938     DOI: 10.1183/09031936.96.09061201

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.

Authors:  Umesh C S Yadav; Mohammad Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-11       Impact factor: 4.799

Review 2.  Clinical anatomy of the inferior labial gland: a narrative review.

Authors:  Daniel Shen; Kisho Ono; Quang Do; Hiroe Ohyama; Ken Nakamura; Kyoichi Obata; Soichiro Ibaragi; Koichi Watanabe; R Shane Tubbs; Joe Iwanaga
Journal:  Gland Surg       Date:  2021-07

3.  Diagnostic management of patients with suspected ocular sarcoidosis.

Authors:  Kazuto Takada; Shuuichi Matsumoto; Eiji Kojima; Susumu Iwata; Kentarou Tanaka
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

4.  Low dose corticosteroid in association with methotrexate for therapy of ocular sarcoidosis: report of a case.

Authors:  Grasiane Nunes Mayer; Morgana Longo; Bárbara Brandi Gomes; Mário Junqueira Nóbrega
Journal:  Int J Retina Vitreous       Date:  2015-06-26

5.  Systemic Sarcoidosis Presenting with Headache and Stroke-Like Episodes.

Authors:  J Campbell; R Kee; D Bhattacharya; P Flynn; M McCarron; A Fulton
Journal:  Case Reports Immunol       Date:  2015-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.